# A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions

> **NCT00864162** · PHASE1 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ramipril10 mg Capsules, single dose
- **DRUG:** Atlace® 10 mg capsules, single dose

## Key facts

- **NCT ID:** NCT00864162
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2004-10
- **Final completion:** 2004-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864162, "A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00864162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*